Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs76056412 | chr1:1157974 | A/G | 2.57E-10 | 487 | 31.27 | 30.73 | 13.73 | KM Plot |
| PRAD | rs7607147 | chr2:107440303 | T/C | 0.000115 | 492 | 30.87 | 30.7 | 32.63 | KM Plot |
| PRAD | rs7607635 | chr2:107446918 | A/C | 0.000113 | 494 | 30.8 | 31.27 | 32.63 | KM Plot |
| PRAD | rs7608410 | chr2:107450390 | C/T | 0.000122 | 494 | 30.8 | 31.07 | 32.63 | KM Plot |
| PRAD | rs76102143 | chr9:72835473 | T/C | 1.75E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
| PRAD | rs7611048 | chr3:112507399 | A/G | 2.15E-7 | 494 | 17.77 | 33.1 | 30.8 | KM Plot |
| PRAD | rs7616382 | chr3:151097666 | T/A | 3.14E-5 | 488 | 17.9 | 28.65 | 31.35 | KM Plot |
| PRAD | rs76163871 | chr5:154110667 | G/A | 0 | 477 | 29.97 | 33.07 | 4.87 | KM Plot |
| PRAD | rs76170986 | chr2:239195894 | C/G | 8.93E-6 | 487 | 31 | 30.35 | 11.57 | KM Plot |
| PRAD | rs76187039 | chr6:43233990 | G/T | 6.95E-5 | 488 | 31.28 | 28.35 | 21.57 | KM Plot |
| PRAD | rs76207590 | chr6:7203995 | A/C | 0.00013 | 492 | 32.4 | 27.67 | 26.95 | KM Plot |
| PRAD | rs76257117 | chr11:129945178 | A/G | 1.17E-5 | 492 | 30.87 | 33.13 | 22.67 | KM Plot |
| PRAD | rs76259539 | chr5:154227873 | G/A | 4.44E-16 | 493 | 29.97 | 37.43 | 16.13 | KM Plot |
| PRAD | rs7627901 | chr3:45919392 | T/C | 3.43E-5 | 480 | 32.9 | 27.77 | 8.77 | KM Plot |
| PRAD | rs76326669 | chr1:220263461 | T/G | 4.25E-5 | 481 | 31.23 | 24.9 | 39.5 | KM Plot |